Showing results (111-120 of 121) with videos related to
Sort By:
Pageof 13
American Journal of Clinical Pathology|February 24, 2001
Usefulness and reproducibility of cytomorphologic evaluations to differentiate myeloma from monoclonal gammopathies of unknown significanceF Millá, A Oriol, J Aguilar, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 8, 2014
Combined analysis of copy number alterations by single-nucleotide polymorphism array and MYC status in non-metastatic breast cancer patients: comparison according to the circulating tumor cell statusR Nadal, M Salido, L Nonell, et al.Leukemia|January 31, 2019
European recommendations and quality assurance for cytogenomic analysis of haematological neoplasmsK A Rack, E van den Berg, C Haferlach, et al.Blood|October 25, 2001
Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignanciesT Sonoki, L Harder, D E Horsman, et al.Leukemia|August 23, 2001
Detection of translocations affecting the BCL6 locus in B cell non-Hodgkin's lymphoma by interphase fluorescence in situ hybridizationD Sanchez-Izquierdo, R Siebert, L Harder, et al.Leukemia|December 21, 2007
Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteriaE Matutes, D Oscier, C Montalban, et al.Leukemia|June 22, 2013
Monosomal karyotype in MDS: explaining the poor prognosis?J Schanz, H Tüchler, F Solé, et al.Leukemia|May 15, 2007
A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-translocationJ I Martín-Subero, R Ibbotson, W Klapper, et al.Blood Cancer Journal|March 14, 2015
The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromesK L McGraw, L M Zhang, D E Rollison, et al.Journal of Hematology & Oncology|July 26, 2018
Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemiaE Genescà, A Lazarenkov, M Morgades, et al.Pageof 13